Since the beginning of this year, few sectors have achieved positive returns, but some big overseas pharmaceutical companies have far outperformed the market.

Recently, a number of US health care stocks have continued to rise, among which, among the related stocks with a market capitalization of more than $10 billion$Merck & Co (MRK.US)$、$Cigna (CI.US)$、$Vertex Pharmaceuticals (VRTX.US)$、$Alnylam Pharmaceuticals (ALNY.US)$、$Gilead Sciences (GILD.US)$、$Regeneron Pharmaceuticals (REGN.US)$、$Novo-Nordisk A/S (NVO.US)$It hit a 360-day high overnight, and a number of stocks are up more than 40% this year.

In view of the cooling of US economic growth and inflation next year, Morgan Stanley's chief investment officer Mike WilsonIt is recommended that defensive positions be maintained in health care, utilities and consumer essential stocks.

It is worth mentioning that the rise of the pharmaceutical sector is not a carnival of the US stock market alone: Hong Kong stocks have also opened a market feast.With the recent domestic epidemic prevention and control policy gradually liberalized, Hong Kong stocks biomedical sector obvious signs of recovery.Open source securities believe that

The pharmaceutical sector is greatly affected by the policy. after experiencing the disturbance of the epidemic and the reduction of collective mining prices, the decline has been divorced from the fundamentals, and the valuations of a large number of high-quality enterprises are at the bottom of history.Under the collective recovery of the industry, subdivision tracks such as pharmaceutical consumption and innovation are expected to usher in recovery and growth, and the industry as a whole may usher in a "Davis double-click" (buy stocks at a low price-to-earnings ratio and sell at a high price-to-earnings ratio when the growth potential becomes apparent).

According to collation, as of the latest closing date, since mid-October, a number of health care stocks in the US stock market have risen more than 20% against the market, including $Intuitive Surgical (ISRG.US) $, $Moderna Inc (MRNA.US) $, $Gilead Sciences Inc (GILD.US) $, etc. In the Hong Kong stock market, $Alibaba Health Information Technology (00241.HK) $and $JD Health (06618.HK) $in the Internet medical industry are very outstanding, rising more than 180% and 100% respectively. In addition, $Pharmaron Beijing Co., Ltd.* (03759.HK) $and $Shanghai Fosun Pharmaceutical (02196.HK) $are also up more than 30%.